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Recognition of microbial glycolipids 
by natural killer T cells
Dirk M. Zajonc* and Enrico Girardi †
Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA
T cells can recognize microbial antigens when presented by dedicated antigen-presenting 
molecules. While peptides are presented by classical members of the major histocom-
patibility complex (MHC) family (MHC I and II), lipids, glycolipids, and lipopeptides can 
be presented by the non-classical MHC member, CD1. The best studied subset of 
lipid-reactive T cells are type I natural killer T (iNKT) cells that recognize a variety of different 
antigens when presented by the non-classical MHCI homolog CD1d. iNKT cells have 
been shown to be important for the protection against various microbial pathogens, 
including B. burgdorferi, the causative agents of Lyme disease, and S. pneumoniae, 
which causes pneumococcal meningitis and community-acquired pneumonia. Both 
pathogens carry microbial glycolipids that can trigger the T cell antigen receptor (TCR), 
leading to iNKT cell activation. iNKT cells have an evolutionary conserved TCR alpha 
chain, yet retain the ability to recognize structurally diverse glycolipids. They do so using a 
conserved recognition mode, in which the TCR enforces a conserved binding orientation 
on CD1d. TCR binding is accompanied by structural changes within the TCR binding 
site of CD1d, as well as the glycolipid antigen itself. In addition to direct recognition 
of microbial antigens, iNKT cells can also be activated by a combination of cytokines 
(IL-12/IL-18) and TCR stimulation. Many microbes carry TLR antigens, and microbial 
infections can lead to TLR activation. The subsequent cytokine response in turn lower 
the threshold of TCR-mediated iNKT cell activation, especially when weak microbial or 
even self-antigens are presented during the cause of the infection. In summary, iNKT 
cells can be directly activated through TCR triggering of strong antigens, while cytokines 
produced by the innate immune response may be necessary for TCR triggering and 
iNKT cell activation in the presence of weak antigens. Here, we will review the molecular 
basis of iNKT cell recognition of glycolipids, with an emphasis on microbial glycolipids.
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introduction
Microbial antigens can be recognized by various receptors of both the innate and adaptive immune 
system. While many receptors, especially innate immune receptors, bind their antigen in free form, 
T cell antigen receptors (TCRs), which are exclusively expressed on T cells, have evolved to recognize 
antigens when presented by dedicated antigen-presenting molecules (1). This feature distinguishes 
them from soluble immunoglobulins (Igs), which can bind to virtually any molecule in solution, 
even though, the Ig fragment that is responsible for antigen binding (Fab) is structurally very similar 
to the TCR. While exceptions to this rule exist, such as gamma delta (γδ) TCRs, which can bind 
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antigens with or without antigen-presenting molecules (2), for 
the purpose of this review, we will exclusively focus on cells car-
rying the more well-characterized αβ TCRs.
T lymphocytes are key cells of the adaptive immune sys-
tem. They recognize infection, initiate, and regulate immune 
responses, especially by controlling the activation of bystander 
immune cells (3). The hallmark of T cell activation is the direct 
binding of the TCR to an antigen that is presented by major 
histocompatibility complex (MHC)-encoded molecules. While 
classical MHC class I or II molecules are important for peptide 
presentation, non-classical MHC molecules, especially CD1, 
are required for glycolipid presentation to T cells (4–8). Other 
non-peptidic antigens, such as microbial vitamin B metabolites, 
can also be recognized by T cells when they are presented by the 
non-classical MHC I molecule, MR1 (9, 10).
The CD1 Family
First identified in the late 1980s in the group of Cesar Milstein, 
CD1 is a group of MHC class I-like antigen-presenting molecules 
(11). CD1 proteins exhibit little or no polymorphism, in stark 
contrast to the MHC-encoded antigen-presenting molecules. 
However, the number of expressed CD1d genes varies widely by 
species. Humans express five functional isotypes (CD1a-e) (12), 
with CD1e being the only member that does not directly present 
antigens to T cells (13). Mice express only CD1d, while other 
species, such as guinea pigs, express multiple forms of the same 
isotpye, CD1b (14). CD1 molecules are conserved throughout 
vertebrate evolution (15) and have been identified to present 
lipids, lipopeptides, and glycolipids. While we will exclusively 
focus on the presentation and T cell recognition of glycolipids, it 
should be noted that the CD1-mediated presentation of phospho-
lipids and lipopeptides is also well characterized (16–20).
CD1 Structure
CD1 overall resembles MHC I molecules, where the heavy chain 
(MHC or CD1) non-covalently associates with β2-microglobulin 
(β2m) (4). The heavy chain can further be divided into three 
domains. The N-terminal α1 and α2 domains together form the 
antigen-binding site, while the α3-domain pairs with β2m to 
support the α1–2 platform. The CD1 binding groove is formed 
by two anti-parallel α-helices that sit atop an anti-parallel β-sheet 
platform. CD1 has evolved a hydrophobic antigen-binding 
groove, which is deeper than that of MHCI and well suited for 
the binding and presentation of hydrophobic molecules, such as 
lipids (4). For in-depth information about the structural details 
of different CD1 isoforms and species, see Ref. (21–32). Each 
CD1 protein has adopted isoform and species-specific binding 
pockets that differ in shape and size; however, all mammalian 
CD1 binding grooves contain the two major pockets, A′ and F′. 
While the A′ pocket is larger, donut shaped, and deeply buried, 
the F′ pocket is more open and accessible to the solvent. Each 
hydrophobic pocket generally binds one alkyl chain of a dual 
alkyl chain glycolipid, while the carbohydrate portion is located at 
the CD1d surface for TCR interaction. TCR recognition requires 
the proper presentation of the glycolipids by CD1d and TCR 
binding of the exposed carbohydrate epitope in conjunction with 
CD1d. The lipid backbone itself can also be in contact with the 
TCR to varying degrees; however, its main role is to anchor and 
orient the carbohydrate for T cell recognition (33). Previously, 
we assumed that the CD1d-binding groove is rather rigid and 
that each lipid will have to find the right fit inside both pockets. 
However, we now know that especially at the surfaces above both 
A′ and F′ pockets, subtle structural changes can be induced upon 
lipid and/or TCR binding (26, 33–35). Lipid-induced structural 
changes in mouse CD1d have only been observed by using 
synthetic glycolipids and whether natural lipids exist that have 
the same effect is currently unknown. However, lipid-induced 
structural changes especially around the F′ pocket greatly influ-
ence iNKT cell activation (33, 36) as this is the primary binding 
site for the TCR (37, 38).
Lipid-Reactive T Cells
Lipid-reactive T lymphocytes are a minor population compared 
to peptide reactive T cells but have been reported to influence the 
outcome of the immune response (3). Lipid-reactive T cell, espe-
cially those expressing an αβ TCR can be divided further based 
on their CD1 restriction and antigen-reactivity. Human group I 
CD1 (CD1a–c)-restricted T cells are generally considered diverse 
in their TCR repertoire and have often been reported to recognize 
mycobacterial antigens as well as self-antigens (39–46). Group 
II CD1 (CD1d)-restricted T cells, also called NKT cells, on the 
other hand, can further be classified into type I (Vα14i, iNKT) 
and type II NKT cells based on their TCR expression. Type I 
NKT cells are characterized by their evolutionarily conserved 
TCRα chain rearrangement [TRAV11–TRAJ18 (Vα14Jα18) in 
mice and TRAV10–TRAJ18 (Vα24Jα18) in human] and their 
reactivity toward the prototypical antigen α−galactosylceramide 
(αGalCer) (Figure  1), while type II NKT cells do not have a 
common antigen and represent all the remaining CD1d-reactive 
T cells that do not react to αGalCer (6, 47, 48). Recently, a 
population of CD1b-restricted T cells, called germline-encoded 
mycolyl lipid-reactive (GEM) T cells has been identified that 
similar to type I NKT cells, use a more restricted TCRαβ reper-
toire (predominantly TRAV1–2–TRAJ9) to bind mybobacterial 
antigens with high affinity (49). Type I NKT cells in particular 
have been identified as important in the protection against vari-
ous microbial pathogens through direct recognition of microbial 
glycolipids.
Microbial Activation of Type i NKT Cells
Cytokine-Mediated Activation with  
and without TCR Stimulus
Type I NKT cells have been shown to participate in protection of 
mice from a variety of microbial parasites (3, 50, 51). While type 
I NKT cells expand upon infection, this is not necessarily due 
to the direct recognition of microbial antigens by the TCR (52). 
Furthermore, type I NKT cells can be activated in vitro and in vivo 
directly by cytokines, such as IL-12 plus IL-18 (53), or IL-12 alone, 
even in the apparent absence of a TCR signal (54) (Figure  2). 
Mouse cytomegalovirus infection leads to the activation of type I 
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NKT cells in a CD1d-independent but IL-12-dependent manner, 
hinting to a protective role of type I NKT cells in viral infection 
(55, 56). Even in the case of bacterial infection, where foreign, 
microbial antigens are present, type I NKT cells can be activated 
with the help of cytokines, such as IL-12, and perhaps in some 
cases, in conjunction with the presentation of self-antigens rather 
than microbial antigens (57, 58). This has been demonstrated 
in the case of Streptococcus pneumoniae infection, where type I 
NKT cell activation is strongly dependent on IL-12, while CD1d 
deficiency greatly reduced but did not fully abrogate NKT cell 
activation (59).
FiGURe 1 | Microbial glycolipids and their presentation by CD1d.  
(A) Chemical drawings of microbial glycolipid ligands. (B) Cartoon of 
glycolipid presentation by CD1d. The α1–α2-domain (green, salmon 
shading) form the two major pockets A′ and F′ of CD1d that bind the lipid 
backbone, while the carbohydrate epitope is exposed. The α3-domain 
(brown) non-covalently binds β2-microblobulin (β2m, blue) and together 
supports the α1–α2-domain of CD1d. (C) Binding orientation of the different 
glycolipid headgroups superimposed in the CD1d binding groove. 
Hydrogen bonds between αGalCer and the CD1d molecule are shown as 
dashed lines.
Glycolipid Activation of Type i NKT
The first antigen shown to activate type I NKT cells was 
α-galactosyl ceramide (αGalCer), which was isolated from a 
marine sponge in a screen for compounds that prevented tumor 
metastases in mice and changed by medicinal chemistry from 
the parental compound, Agelasphin-9b (Figure  1). αGalCer is 
now widely considered the prototypical antigen for human and 
mouse type I NKT cells. αGalCer is a glycosphingolipid, in which 
an α-anomeric galactose is connected to a ceramide backbone. 
The ceramide consists of a sphingoid base, which carries an 
N-amide-linked saturated C26 acyl chain. Interestingly, a new 
FiGURe 2 | indirect and direct activation of NKT cells. Dendritic 
cells produce IL-12 and IL-18 upon activation by TLR agonists that 
together with TCR engagement of weak microbial or self-antigens lead to 
the activation of iNKT cells (left pathway). DC presentation of microbial 
antigens can directly activate iNKT cells through TCR engagement (right 
pathway).
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study identified α-glycosyl ceramides in immune cells in mice, 
where they could play an important role in the development of 
iNKT cells (60, 61).
αGalCer binds to CD1d with the C26 acyl chain in the A′ 
pocket and the sphingoid base in the F′ pocket (Figure 1). This 
binding orientation exposes the galactose moiety above the 
CD1d-binding groove for interaction with the TCR and subse-
quent NKT cell activation.
Glycosphingolipids from Sphingomonas spp
The first identified and characterized microbial antigen for type I 
NKT cells was a glycosphingolipid from Sphingomonas bacteria. 
Sphingomonas are Gram-negative bacteria that lack lipopolysac-
charide (LPS) and are highly abundant in the environment, 
including sea water (62, 63). Although Sphingomonas is not 
highly pathogenic, mice lacking type I NKT cells are defective for 
clearance of Sphingomonas yanoikuyae at early times after infec-
tion, while at later times, the bacteria was cleared without signs of 
any damage (64, 65). While the original TRAJ18−/− mice used in 
those studies had a lower TCR repertoire, which could potentially 
contribute to some of the observed effects, a new mouse strain 
lacking iNKT cells is now available to assess the contribution of 
iNKT cells in host defense and other disease models (66, 67).
Similar to αGalCer, the antigen GalA-GSL also carried an 
α-linked sugar connected to a ceramide backbone (64, 68). 
However, instead of a galactose, the most potent antigen con-
tained a galacturonic acid, while the ceramide lacked a hydroxyl 
group at C4 of the sphingoid base (Figure 1). In addition, instead 
of the C26 acyl chain found in αGalCer, GalA-GSL contains a 
much shorter C14 fatty acid.
Borrelia burgdorferi Galactosyl  
Diacylglycerol Antigens
Borrelia burgdorferi is a spirochete and the causative agent of 
Lyme disease. Mice lacking type I NKT cells were less capable 
of clearing B. burgdorferi and they were more subject to chronic 
joint inflammation (69–71). One week after bacterial infection, 
type I NKT cells were activated in  vivo to produce cytokines, 
such as IFNγ and IL-4 (70). B. burgdorferi is the first example of a 
pathogenic microbe that contain glycolipid antigens that activates 
type I NKT cells, and it is also the first example showing that type 
I NKT cell antigens do not have to be glycosphingolipids (72). 
B. burgdorferi has abundant glycosylated diacylglycerols (73, 74) 
with an α-anomeric galactose sugar in the sn-3 position of the 
glycerol. The sn-1 and sn-2 positions carry different acyl chains, 
most prominently palmitate (C16:0), stearate (C18:0), oleate 
(C18:1), and linoleate (C18:2) (Figure 1).
Using synthetic versions of the diacylglycerol antigen from B. 
burgdorferi, carrying different acyl chains at both sn-1 and sn-2 
position, revealed the impact of the lipid backbone in type I NKT 
cell activation. The glycolipid, BbGL-2c (sn-1, oleate, sn-2, palmi-
tate) proved to be stimulatory for mouse type I NKT cells, while 
BbGl-2f (sn-1, linoleate, sn-2, oleate) was the preferred antigen for 
human type I NKT cells (72, 75). The data suggested that despite 
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having an α-anomeric galactose for TCR recognition, identical 
to αGalCer, the nature of the lipid backbone that anchors the 
glycolipid to CD1d can influence T cell activation. Although 
diacylglycerol lipids are less potent than sphingolipids, this find-
ing is important since diacylglycerols are widely distributed in 
microbes.
Streptococcus pneumoniae Glucosyl 
Diacylglycerol Antigens
S.pneumoniae and Group B streptococcus are important 
pathogens responsible for pediatric and community-acquired 
pneumonia. α-glucosyl-containing diacylglycerol antigens (Glc-
DAG)-s2, the main iNKT antigen found in these bacteria, was 
the first microbial antigen identified that did not carry a galac-
tosyl moiety (76). Instead, it is composed of an α-linked glucosyl 
hexose linked to a diacylglycerol backbone. Interestingly, the 
sn-2 position of the glycerol carries an unusual vaccenic (C18:1, 
cis-11) acid, while the sn-1 position is occupied by palmitic acid 
(C16:0). The requirement for this unusual combination of sugar 
and fatty acid appears to be quite stringent, as the positional iso-
mer carrying a vaccenic acid in position sn-1 is not antigenic and 
that replacement of the glucosyl moiety with galactose did not 
restore antigenicity (36). Notably, Glc-DAG-s2 is also antigenic in 
human NKT cells (76), suggesting that the importance of similar 
synergies between lipid and polar portion of the streptococcal 
iNKT antigens is maintained in humans.
Bacteroides fragilis Glycosphingolipid Antigens
Bacteroides fragilis is a commensal bacteria found in humans 
and mice, where it colonizes the gut, and is characterized by an 
unusually high percentage of sphingolipds in its membranes. 
iNKT antigens were reported in these bacteria, which structurally 
resemble the prototypical antigen αGalCer (Figure 1) (77, 78), 
while carrying features also found in the original antigenic sphin-
golipid isolated from marine sponges, such as Agelasphin-9b. 
These antigens were found to have either stimulatory or inhibitory 
effects on iNKT cells, playing a critical role in iNKT homestasis 
during development. While no structural information is cur-
rently available on how these antigens are presented by CD1d, 
their structural similarity to well-characterized sphingolipids 
suggests a conserved CD1d-binding mode, with the sphingosine 
chain bound in the F′ pocket and the fatty acid chain in the A′ 
pocket.
Helicobacter pylori Glucosyl  
Cholesterol Antigens
Glycolipid antigens derived from Helicobacter pylori, the bacte-
rium associated with the etiology of gastritis and peptic ulcers, 
have been recently described as cholesteryl α-glucoside antigens 
(79). In particular, the lipid cholesteryl phosphatidyl α-glucoside 
(αCPG) was shown to bind to CD1d and be able to stimulate 
iNKT cells. Clinical severity of gastric atrophy upon infection 
of H. pylori was correlated with the expression of the microbial 
enzyme cholesteryl α-glucosyltransferase (αCgT), which gener-
ates the iNKT cell antigen cholesteryl α-glucoside (79). Jα18-
deficient mice lacking iNKT cells have an elevated burden of H. 
pylori, suggesting a protective role of iNKT cells against certain 
clinical isolates of H. pylori. While this study did not address 
whether the phosphatidyl moiety or the cholesterol moiety binds 
inside the CD1d-binding groove, unpublished data form our own 
lab indicated that the mouse CD1d can in fact bind cholesterol 
derivatives. How such a bulky and rigid lipid moiety is bound 
within the CD1d-binding groove is currently unclear and will 
require further structural characterization.
Entamoeba histolytica Acylated 
Lysophosphatidyl inositol Antigen
Another microbe that contains unusual iNKT cell antigens is 
Entamoeba histolytica, an intestinal protozoan parasite that 
causes amebiasis, resulting in significant morbidity and mortality 
worldwide (80). Clinical manifestations include liver abscesses, 
and animal models of experimental amebic liver abscess (ALA) 
demonstrated a role for IFN-γ in the control of E. histolytica inva-
sion. As iNKT cells are predominantly located in the liver of mice 
and potently produce copious amounts of IFN-γ, it is not sur-
prising that Jα18−/− mice have considerably larger liver abscesses 
compared to wildtype mice, indicating a protective role of iNKT 
cells in parasite control. The iNKT cell antigen was generated 
upon lysosomal processing of a lipopeptidophosphoglycan to 
the active form EhPIb, 1-O-[(28:0)-lyso-glycero-3-phosphatidyl-
]2-O-(16:0)-inositol (81). This lipid correlates with a model in 
which the C28:0 chain binds in the A′ pocket of CD1d, while the 
inositol headgroup is exposed above the CD1d-binding groove 
and the inositol-linked C16 fatty acid inserts into the F′ pocket 
of CD1d. However, no published data using a synthetic version 
of this antigen are available to date, which would be important to 
address the question of how such a structure binds to CD1d to 
activate iNKT cells.
Antigen Loading and Processing
Lipid antigens are generally water-insoluble and if not bound to 
proteins themselves, will be embedded into cellular membranes. 
As a consequence, there has to be an active process in which lipids 
are extracted from the membranes of APCs and/or transferred 
from another protein into the binding groove of CD1d. While 
some antigens, such as αGalCer, can be loaded directly into 
CD1d molecules on the cell surface, antigen presentation gener-
ally is enhanced by the internalization of glycolipids into acidic 
endosomal compartments (82). As cell-surface expressed CD1 
recycles back through cellular compartments, CD1 encounters 
lysosomal lipid transfer proteins, such as saposins A–D (83–87), 
which facilitate the transfer of glycolipids into CD1. Saposins 
can extract lipids from membranes, directly bind them in hydro-
phobic pockets, and transfer them onto CD1d. However, the 
mechanism of lipid transfer and whether saposins directly bind 
CD1d has not been well studied. In addition to saposins, a variety 
of cells, including DCs, secrete apolipoprotein E, which enhances 
the presentation of glycolipid antigens to iNKT cells because it 
can interact with glycosphingolipid antigens and enhance their 
uptake (88). Furthermore, microsomal triglyceride transfer 
protein (MTTP), an ER chaperone protein, has been reported to 
assist in lipid loading into nascent CD1d, as it passes through 
the secretory pathway on the way to the cell surface (89). As a 
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result, endogenous lipids are found associated with cell-surface 
expressed CD1d.
In addition to lipid loading, lipid processing can also occur 
in acidic compartments. Using the synthetic glycosphingolipid 
antigens Gal(α1,2)αGalCer, carbohydrate antigen processing 
was demonstrated in APCs (90). Gal(α1,2)αGalCer itself is 
unable to directly activate iNKT cells but once the terminal 
galactose is removed by the lysosomal enzyme α-galactosidase 
A, thereby generating the highly antigenic monosaccharide, 
αGalCer, iNKT cell activation could be observed (90). Processing 
of microbial antigens has also been observed for the Entamoeba 
histolytica antigen, EhPIb. However, in contrast to the removal of 
a carbohydrate, removal of a fatty acid through a phospholipase 
(PL) is necessary to generate the antigen. Another example of 
microbial antigen processing is provided by hexamannosylated 
phosphatidyl-myo-inositols (PIM6), from Mycobacterium 
tuberculosis, which is presented by CD1b. PIM6 is processed to 
the dimannoside form PIM2 by α-mannosidase, a process that 
is greatly enhanced by CD1e (13). Also, recognition of iGb3 
is believed to require processing from iGb4 by an enzyme or 
enzymes having the β-subunit found in lysosomal hexosamini-
dases A and B (91).
In summary, processing of antigens can occur both in the 
carbohydrate moiety, as well as the lipid backbone and appears to 
constitute a common feature of both endogenous and microbial 
antigens.
Structural Basis of Glycolipid  
Presentation by CD1d
While the list of NKT cell antigens is rapidly expanding, most 
structural work on the presentation of glycolipids by CD1d has 
focused on dual chain lipids, such as diacylglycerol lipids or 
sphingolipids. Only limited structural data are available on the 
presentation of lysolipids, which are characterized by possessing 
only one alkyl chain, or other types of lipids, such as cholesterol 
derivatives. The few current examples of lysolipids include the 
presentation of lyso-PC by human CD1d, which is an antigen 
for iNKT cells and lyso-sulfatide by mouse CD1d, which is an 
antigen for a subset of type II NKT cells (92, 93). Both single 
chain lipids appear to bind in the F′ pocket of CD1d but activate 
distinct NKT cell populations. Lysophospholipids are derived 
from diacylglycerol lipids upon PL A1, A2, or B digestion, gener-
ating lysolipids with a single fatty acid located either at the sn-1 
(PLA2, B) or sn-2 (PLA1, B) position. However, the current list of 
microbial lysolipids able to activate iNKT cells is limited. While 
Entamoeba histolytica contains a lysolipid with a fatty acid at the 
sn-1 (EhPIa), only the lipid that contains an additional fatty acid 
at the inositol moiety (EhPIb) appears to be antigenic for iNKT 
cells (Figure 1) (81).
Microbial dual alkyl chain lipids binding to CD1d have been 
well characterized, both for ceramide-based glycosphingolipids 
and for diacylglycerol-containing glycolipids (33, 36, 64, 68, 72, 
75, 76, 94, 95). We now know that sphingolipids bind in a con-
served orientation to CD1d, with the longer acyl chain (typically 
up to C26) filling the larger A′ pocket, and the shorter sphingoid 
base (~C18) filling the smaller F′ pocket (96, 97). This binding 
orientation is maintained even when the fatty acid or the sphin-
gosine moiety is truncated to eight or nine carbons, respectively, 
which would allow for a reversed binding orientation (26, 98). 
The binding orientation is likely orchestrated by a network of 
conserved H-bond interactions between the core mouse CD1d 
residues, Asp80, Asp153, and Thr156 (Asp151 and Thr154 are 
the equivalent residues in human CD1d) and the polar moieties 
of the rigid ceramide backbone (Figure  1C). If the fatty acid 
chain is too short to fill the A′ pocket completely, spacer lipids, 
such as a C16:0 fatty acids (palmitic acid), are recruited to occupy 
the remainder of the pocket, at least for proteins that were 
recombinantly expressed in insect cells (26, 95, 99). Spacer lipids 
have also been observed in the F′ pocket for glycosphingolipids, 
such as OCH, where the sphingoid base had been shortened (35, 
98). The conserved binding orientation places the carbohydrate 
moiety in a rather similar position for TCR engagement. The 
first identified microbial antigens for iNKT cells were from 
Sphingomonas spp., which contained the glycosphingolipids 
α-glycuronosylceramide (containing either a glucuronic or 
galacturonic moiety). Structural data revealed that the overall 
binding to CD1d was similar compared to αGalCer, with slight 
different interactions based on the lack of the 4-OH group of the 
sphingoid base. This resulted in a slightly deeper binding of the 
sphingoid base inside the F′ pocket and a concomitant loss of well 
conserved electron density for the galacturonic acid headgroup 
at the CD1d surface (95). This less well-defined presentation of 
the headgroup was likely the major determinant for the reduced 
antigenicity compared to αGalCer and a reduced TCR-binding 
affinity (33). Interestingly, a subset of non-canonical Vα10 NKT 
cells had been described earlier that can also recognize αGalCer 
but have a preference for glucose-containing antigens, such as 
αGlcCer, and the microbial antigen, α-glucuronosylceramide. 
Despite sharing only 40% sequence conservation with the Vα14 
chain, the Vα10 NKT cells have a CD1d-docking mode similar 
to type I NKT cells (100). iNKT cell antigens that contain cera-
mide backbones are generally more potent than antigens that are 
based on a diacylglycerol backbone. In fact, the fine structure 
of the diacylglycerol backbone greatly influences the potency of 
iNKT cell agonists. While the carbohydrate moiety is connected 
to the sn-3 position of the glycerol, the two fatty acids occupy 
the sn-1 and sn-2 position. This leads to a greater diversity in 
the lipid backbone of diacylglycerol lipids, as the fatty acids can 
vary in length and saturation. During the structural characteri-
zation of B. burgdorferi α-galactosyl diacylglycerolipid binding 
to mouse CD1d, we observed two binding orientations of the 
diacylglycerolipid backbone. The two antigens, BbGl-2c and 
BbGl-2f, bind with the oleic acid (C18:1) in the A′ pocket and the 
palmitic acid (C16:0, BbGl-2c) or linoleic acid (C18:2, BbGl-2f) 
in the F′ pocket. However, as the oleic acid is at the sn-1 position 
in BbGL-2c but in the sn-2 position on BbGL-2f, this results in 
the reversed binding orientation (Figure 3B). It has been dem-
onstrated that only BbGL-2c can potently activate mouse iNKT 
cells, suggesting that the reversed binding orientation observed 
for BbGL-2f renders the antigen non-antigenic, even though the 
same galactose epitope is presented (75). However, presentation 
of this galactose moiety above the CD1d-binding groove is 
altered, suggesting that the fine positioning of the carbohydrate 
FiGURe 3 | TCR recognition of CD1d-presented glycolipids. (A) Cartoon 
representation of the CD1d–αGalCer–Vα14Vβ8.2 TCR ternary complex.  
(B) Individual fatty acids can affect the binding orientation of diacylglycerolipid 
antigens. BbGl-2c binds with the sn-1-linked oleic acid in the A′ pocket, while 
BbGL-2f inserts its sn-2 linked oleic acid. This affects presentation of the 
galacotse moiety. (C) The glycolipids are exclusively contacted by CRD1α and 
CRD3α residues of the Vα14 chain of the TCRα, while the Vβ8.2 chain is offset 
to the C-terminal end of the α1-helix, and only contacts CD1d directly. Note 
that all glycolipids superimpose well as they are molded into the same position 
by the TCR.
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moiety at the TCR interface by the precise structure of the 
lipid backbone greatly affects antigenicity. It is intriguing to 
speculate that microbes can synthesize specific glycolipids 
in an attempt to invade immune recognition by iNKT cells; 
however, both BbGl-2c and BbGl-2f are abundantly expressed 
by B. burgdorferi (73).
Streptococcus pneumoniae contains α-Glc-DAG, in contrast to 
the galactose or galacturonic acid moieties found in B. burgdorferi 
and Sphingomonas spp. Glucose-containing glycolipids are gener-
ally considered as weaker antigens based on early studies using 
αGalCer analogs (101). The precise lipid structure contained an 
sn-3-linked α-glucose, a palmitic acid at sn-1, and a cis-vaccenic 
acid (C18:1, cis-11) at sn-2 (Glc-DAG-s2) (76). Replacing the 
glucose with a galactose surprisingly resulted in a glycolipid 
that was not able to activate murine iNKT cells (Gal-DAG-s2) 
(36). Similar observations were made when the cis-vaccenic 
fatty acid was replaced against oleic acid (C18:1, cis-9), which 
effectively only shifts the unsaturation two carbons toward the 
end of the chain, or when the cis-vaccenic acid was linked to the 
sn-1, rather than sn-2 position of the glycerol (36, 76). As such, 
the streptococcal antigen exhibited a unique interplay between 
the lipid backbone, the precise location of the unsaturation at the 
sn-2 linked fatty acid, and the glucose moiety. Presentation of this 
glycolipid by CD1d shared similarities with the presentation of 
the borrelial antigen BbGL-2c, which had the oleic acid at the sn-1 
position. While both lipids bound in opposite orientations inside 
the CD1d-binding pocket, both the galactose and the glucose 
moiety were presented in a more upright tilted orientation to the 
TCR. This was a direct consequence of loss of intimate H-bond 
interactions with the core residue Asp153, which binds the 2″- 
and 3″-OH of αGalCer (Figure 1C).
T Cell Recognition of CD1d–Glycolipid 
Complexes
In recent years, structural studies shed light on the recognition 
of the different microbial glycolipids by the Vα14Vβ8.2 TCR 
of murine iNKT cells (33, 36). Similar to the structure of the 
Vα14Vβ8.2 TCR bound to mCD1d-αGalCer (38), the microbial 
antigens are contacted by the TCR using a highly conserved bind-
ing chemistry. The TCR binds with the invariant Vα14Jα18 chain 
directly above the carbohydrate headgroup with a footprint cen-
tered above the F′ pocket. In stark contrast to TCR recognition of 
pMHC, the TCR beta chain does not participate in direct antigen 
recognition. The highly variable complementarity-determining 
region (CDR)3β loop exclusively contacts CD1d and is involved 
in controlling autoreactivity (102). The antigen is recognized 
by the TCR alpha chain, specifically CDR1α and CDR3α. In 
addition, certain antigens, such as isoglobotrihexosyl ceramide 
(iGb3) or phosphatidyl inositol (PI), are also contacted by the 
framework residue, Lys68, while αGalCer analogs with aromatic 
groups attached to the 6″-OH of the galactose can be in contact 
with CDR2α residue Gln52 (103–105). CDR1α exclusively con-
tacts the headgroup, while CDR3α contacts both headgroup, the 
hydroxyls of the lipid backbone, and the F′ roof, indicating that 
the overall recognition and binding orientation is dominated by 
CDR3α (Figure 3). For αGalCer, the 3″ and 4″-OH groups of the 
galactose epitope make a hydrogen bond to Asn30 of CDR1α, 
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while the 2″-OH interacts with the backbone nitrogen of Gly96 
of CDR3α. Arg95 contacts the 4′-OH of the sphingoid base. All or 
most of those interactions are also observed in the microbial gly-
colipid structures but depending on the type of carbohydrate, the 
interaction with the axial 4″-OH can be lacking (e.g., in glucose, 
the 4″-OH is in equatorial configuration, pointing away from the 
TCR). Also, depending on the nature of the lipid backbone, the 
interaction between Arg95 of CRD3α and 4′-OH of the sphingoid 
base is not always formed. Surprisingly, while the carbohydrate 
moieties of three two microbial lipids, GalA-GSL, BbGL-2c, and 
Glc-DAG-s2, are presented by CD1d in different orientations 
before TCR engagement, all the lipid headgroups superimpose 
well with that of αGalCer after TCR binding. The combined 
biophysical and structural data revealed the basis of why αGalCer 
is such a potent antigen and high affinity ligand for the TCR. 
The TCR binds αGalCer using a lock and key mechanism, while 
microbial antigens, especially the carbohydrate headgroups have 
to be re-oriented by the TCR to allow for the conserved binding 
footprint on CD1d (33, 37, 106, 107). One could argue that the 
lipid structures of the analyzed microbial antigens are similar to 
αGalCer, despite the obvious differences in the lipid backbones. 
As such, the TCR not surprisingly binds to those antigens using 
a conserved binding chemistry. However, the conserved bind-
ing chemistry of the TCR has also been observed in the more 
complex β-anomeric glycolipid, iGb3, where the TCR completely 
flattens the trihexosyl group to form similar interactions with the 
β-anomeric glucose. In fact, the β-anomeric glucose is molded 
upon TCR binding into a position where it mimics the observed 
flat binding of α-anomeric carbohydrates (104, 108). TCR-binding 
kinetics also correlates well with the structural change that the 
TCR induces in the ligands upon binding to the CD1d–glycolipid 
complexes. All the microbial antigens that are not based on a 
ceramide backbone and as such differently presented by CD1d 
have a 10× or more reduced TCR association rate. Surprisingly, 
however, the TCR dissociates 70× faster from GalA-GSL com-
pared to αGalCer. While both antigens are presented in a similar 
orientation, and also form the same number of H-bond interac-
tions, we wondered whether there are any structural changes in 
CD1d. Indeed, as previously reported, the short chain αGalCer 
analog PBS-25 induces the closure of the F′ roof upon binding 
to CD1d, while the F′ roof is not closed by any of the microbial 
antigens (26, 33, 36). The F′ roof is the major binding site for the 
TCRα chain and upon binding of the TCR, the F′ roof is formed 
regardless of the bound glycolipid. That correlates with a model in 
which the TCR induces a structural change in CD1d for the TCRα 
chain to bind to, and the necessary binding energy to keep the 
roof closed is taken out of the TCR binding energy. As a result, the 
TCR dissociates faster from CD1d–glycolipid complexes that do 
not have a preformed F′ roof (33, 36). Further mutational stud-
ies targeting individual residues within the F′ roof highlighted 
the importance of this roof in the overall stability of the ternary 
complexes, without affecting TCR association rates, suggesting a 
two step-binding mechanism in which the antigen is bound first 
and then the CD1d molecule (36).
Conclusion
The TCR of iNKT cells can recognize a vast range of antigens. 
While novel microbial antigens for iNKT cells continue to be 
identified, a clear structural pattern has emerged that the TCR 
recognizes with preferred specificity. The pattern consists of an 
α-anomeric monohexosyl sugar, linked to a lipid backbone that 
can either be based on a ceramide, a diacylglycerol, or potentially 
a cholesterol moiety. The type of sugar that is preferentially recog-
nized would depend on the precise structure of the lipid backbone 
but generally contains a galactose, glucose, or derivatives thereof. 
While it is still difficult to predict which DAG backbone would 
give rise to iNKT cell antigens, the binding of glycosphingolipids 
is more conserved and many interactions with the TCR can now 
be modeled with confidence. Deviation from this pattern can be 
compensated by the unique binding properties of the TCR, with 
regards to the structural changes that it can induce in both lipid 
headgroup orientation and in CD1d. Those changes would be 
reflected in a lower TCR binding affinity and potency. As such, 
the most potent glycolipid antigens for iNKT cells, regardless of 
source, are glycosphingolipids followed by α-glycosyl diacylglyc-
erolipids. Binding of other types of lipid antigens has not been 
structurally assessed but will be the focus of continuing studies, 
since many microbes also produce glycolipids that deviate from 
the known structures.
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